These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 21428974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM, Armario-Hita JC.
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC, Leenarts MF, Meijerink-van 't Oost L, Mekkes JR.
    J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
    [Abstract] [Full Text] [Related]

  • 8. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL, Lowe L, Kang S.
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [Abstract] [Full Text] [Related]

  • 9. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L, Dupuy A, Kerob D, Levy A, Allez M, Begon E, Bachelez H, Morel P, Lebbé C.
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA, Callejas-Rubio JL, Sánchez-Cano D, González-Martínez FJ, Navas-Parejo A, Ortego-Centeno N.
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V, Mrowietz U.
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
    van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP.
    Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
    [Abstract] [Full Text] [Related]

  • 18. New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab.
    Acquacalda E, Roux CH, Albert C, Breuil V, Passeron T, Euller-Ziegler L.
    Joint Bone Spine; 2015 Oct; 82(5):362-4. PubMed ID: 25776450
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.